PURPOSE: This study assessed the potential exposure risks for workers in the workplace exposed to airborne titanium dioxide nanoparticles (TiO(2)-NPs) and carbon black nanoparticles (CB-NPs). The risk management control strategies were also developed for the NP engineering workplace. METHODS: The method used in this study was based on the integrated multiple-path particle dosimetry model to estimate the cumulative dose of nanoparticles (NPs) in the human lung. The study then analyzed toxicological effects such as pulmonary cytotoxicity and inflammation and evaluated the health risk associated with exposure to NPs in the workplace. Risk control measures such as the use of ventilating systems and N95 respirator protection are also discussed. RESULTS AND DISCUSSION: This study found that: (1) the cumulative dose of CB-NPs was greater than that of TiO(2)-NPs in human lungs; (2) there is a potential health risk to workers exposed to TiO(2)-NPs and CB-NPs in the absence of control measures in the workplace, with higher health risks associated with CB-NPs than TiO(2)-NPs; and (3) the use of a ventilating system and an N95 respirator offers greater protection in the workplace and significantly reduces the health risks associated with NP exposure. CONCLUSION: The present risk management control strategy suggests that the most effective way to reduce airborne NPs is to incorporate the use of a ventilating system combined with N95 respirator protection. This will enable the concentrations of TiO(2)-NPs and CB-NPs to be reduced to acceptable exposure levels.
PURPOSE: This study assessed the potential exposure risks for workers in the workplace exposed to airborne titanium dioxide nanoparticles (TiO(2)-NPs) and carbon black nanoparticles (CB-NPs). The risk management control strategies were also developed for the NP engineering workplace. METHODS: The method used in this study was based on the integrated multiple-path particle dosimetry model to estimate the cumulative dose of nanoparticles (NPs) in the human lung. The study then analyzed toxicological effects such as pulmonary cytotoxicity and inflammation and evaluated the health risk associated with exposure to NPs in the workplace. Risk control measures such as the use of ventilating systems and N95 respirator protection are also discussed. RESULTS AND DISCUSSION: This study found that: (1) the cumulative dose of CB-NPs was greater than that of TiO(2)-NPs in human lungs; (2) there is a potential health risk to workers exposed to TiO(2)-NPs and CB-NPs in the absence of control measures in the workplace, with higher health risks associated with CB-NPs than TiO(2)-NPs; and (3) the use of a ventilating system and an N95 respirator offers greater protection in the workplace and significantly reduces the health risks associated with NP exposure. CONCLUSION: The present risk management control strategy suggests that the most effective way to reduce airborne NPs is to incorporate the use of a ventilating system combined with N95 respirator protection. This will enable the concentrations of TiO(2)-NPs and CB-NPs to be reduced to acceptable exposure levels.
Authors: Alison Elder; Robert Gelein; Jacob N Finkelstein; Kevin E Driscoll; Jack Harkema; Günter Oberdörster Journal: Toxicol Sci Date: 2005-09-21 Impact factor: 4.849
Authors: Peter Morfeld; Sebastian F Büchte; Jürgen Wellmann; Robert J McCunney; Claus Piekarski Journal: J Occup Environ Med Date: 2006-12 Impact factor: 2.162
Authors: Muhammad Sajid; Muhammad Ilyas; Chanbasha Basheer; Madiha Tariq; Muhammad Daud; Nadeem Baig; Farrukh Shehzad Journal: Environ Sci Pollut Res Int Date: 2014-12-30 Impact factor: 4.223
Authors: Antti J Koivisto; Jaana E Palomäki; Anna-Kaisa Viitanen; Kirsi M Siivola; Ismo K Koponen; Mingzhou Yu; Tomi S Kanerva; Hannu Norppa; Harri T Alenius; Tareq Hussein; Kai M Savolainen; Kaarle J Hämeri Journal: Int J Environ Res Public Health Date: 2014-05-16 Impact factor: 3.390
Authors: Tamara Horváth; András Papp; Nóra Igaz; Dávid Kovács; Gábor Kozma; Vivien Trenka; László Tiszlavicz; Zsolt Rázga; Zoltán Kónya; Mónika Kiricsi; Tünde Vezér Journal: Int J Nanomedicine Date: 2018-11-02